Exagen XGN
NASDAQ XGN
$8.17 +0.28 (+3.55%)
At close: Oct 2, 2026 · 4:00 PM EDT

Exagen (XGN) Gains from Sales and Divestitures (2018 - 2025)

Updated

Exagen's Gains from Sales and Divestitures was -$6,000 in Q1 2025, compared with -$36,000 a year earlier.

Analysis

Exagen (XGN) Gains from Sales and Divestitures (2018 - 2025) Analysis & Trends

On a trailing twelve-month basis, Exagen's Gains from Sales and Divestitures was -$81,000 through Mar 31, 2025; for FY2024, it came in at -$111,000.

  • In earlier years, Gains from Sales and Divestitures was -$189,000 in FY2023.
  • The Q1 2025 figure marks the highest quarterly Gains from Sales and Divestitures since Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.08 Bn 92.52 Bn -
2 Natera 58.93 Bn 54.61 Bn 485.19 Mn
3 Quest Diagnostics 25.75 Bn 24.18 Bn 1.03 Bn
4 Labcorp Holdings 24.96 Bn 22.73 Bn 1.11 Bn
5 Guardant Health 23.76 Bn 19.82 Bn 219.03 Mn
6 Tenet Healthcare 20.83 Bn 11.98 Bn -
7 Tempus AI 13.43 Bn 10.46 Bn 246.50 Mn
8 BrightSpring Health Services 11.90 Bn 10.24 Bn 492.75 Mn
9 Encompass Health 11.82 Bn 12.29 Bn -
10 Exagen 197.66 Mn 83.62 Mn 12.22 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -6,000.00
Jun 30, 2024 -75,000.00
Mar 31, 2024 -36,000.00
Dec 31, 2023 20,000.00
Sep 30, 2023 -80,000.00
Jun 30, 2023 -74,000.00
Mar 31, 2023 -55,000.00
Sep 30, 2019 197,000.00
Jun 30, 2019 -213,000.00
Mar 31, 2019 -4,000.00
Dec 31, 2018 -6,000.00
API Access

Exagen Gains from Sales and Divestitures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-sales-and-divestitures&ticker=XGN&period=max&api_key=YOUR_API_KEY